Rheumatism
Conditions
Brief summary
Patients with chronic inflammatory rheumatism (RIC) or autoimmune diseases, rheumatoid arthritis and spondyloarthritis, are regularly monitored in consultation as part of a treat to target strategy with rapid adaptation of treatments to the activity of their disease. according to French recommendations. They are treated with immunosuppressive drugs: disease-modifying treatments with very often methotrexate, associated with biotherapies or targeted therapies (JAK inhibitors) They can also be treated transiently or over the long term with corticosteroids. These treatments expose them to greater infectious risks, especially with regard to COVID19. The objective is on the one hand to assess the impact of the Covid 19 pandemic on general state of health of these patients and the evolution of their disease and on the other hand to prioritize the optimal care of these patients by including in the context of maintaining the pandemic reduction rules, modern telemedicine technologies.
Interventions
OTHERquestionnaires
Questionnaire completion
Sponsors
University Hospital, Limoges
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
All patients with chronic inflammatory rheumatism followed in the rheumatology department of the CHU de Limoges.
Exclusion criteria
Patients who object to the use of their data.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| post-traumatic stress | Day 1 | Presence or absence of post-traumatic stress disorder due to the COVID19 pandemic assessed by the Post-traumatic stress disorder Check-list version DSM-5 (PCL-5) |
Countries
France
Contacts
Primary ContactPhilippe BERTIN, MD
Backup ContactCorinne TRAPY
Outcome results
None listed